Neil C Sheppard

12PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 05, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels.

|Apr 07, 2026
HLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack.

Kimberly Apodaca, Chong Xu, Kelsey L Stanton

|May 10, 2024
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation.

Abdulla Berjis, Deeksha Muthumani, Oscar A Aguilar

|Mar 16, 2024
Author Correction: Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager.

Ningqiang Gong, Xuexiang Han, Lulu Xue

|Feb 20, 2024
Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager.

Ningqiang Gong, Xuexiang Han, Lulu Xue

|Feb 08, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.

Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski

Pageof 2

Frequent Collaborators

7 joint publications

Carl H June

3 joint publications

James L Riley

3 joint publications

Adam D Cohen

3 joint publications

Alfred L Garfall